4SC AG (FRA:VSC) Cash-to-Debt : No Debt ⁽¹⁾ (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is 4SC AG Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. 4SC AG's cash to debt ratio for the quarter that ended in Dec. 2023 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, 4SC AG could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for 4SC AG's Cash-to-Debt or its related term are showing as below:

FRA:VSC' s Cash-to-Debt Range Over the Past 10 Years
Min: 10.1 Med: 5012.65 Max: No Debt
Current: No Debt

During the past 13 years, 4SC AG's highest Cash to Debt Ratio was No Debt. The lowest was 10.10. And the median was 5012.65.

FRA:VSC's Cash-to-Debt is ranked better than
99.74% of 1539 companies
in the Biotechnology industry
Industry Median: 6.49 vs FRA:VSC: No Debt

4SC AG Cash-to-Debt Historical Data

The historical data trend for 4SC AG's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

4SC AG Cash-to-Debt Chart

4SC AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

25.30

23.18

20.73

No Debt

4SC AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															20.73	No Debt	No Debt	No Debt	No Debt

Competitive Comparison of 4SC AG's Cash-to-Debt

For the Biotechnology subindustry, 4SC AG's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4SC AG's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4SC AG's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where 4SC AG's Cash-to-Debt falls into.

4SC AG Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

4SC AG's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

4SC AG had no debt ⁽¹⁾.

4SC AG's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

4SC AG had no debt ⁽¹⁾.

4SC AG (FRA:VSC) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

4SC AG Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of 4SC AG's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

4SC AG (FRA:VSC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (FRA:VSC) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

VSC:Germany

Address

Fraunhoferstraße 22, Planegg-Martinsried, DEU, 82152

Website

https://www.4sc.com

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. It Geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.

4SC AG (FRA:VSC) Headlines

No Headlines

4SC AG (FRA:VSC) Cash-to-Debt : No Debt (1) (As of Dec. 2023)